IMSI (high-magnification sperm selection)
Selecting sperm under very high magnification before ICSI.
Written by Fertility Decoded. Reviewed by D R, MS (OBG), FRM. Review date: 31 August 2026.
The verdict
Not shown to improve outcomes.
Who are these bodies?
- HFEA
- — UK fertility regulator; rates add-ons by evidence (traffic-light).
- ESHRE
- — European fertility society; evidence-based practice guidance.
- NICE
- — UK health-guidance body; what the NHS will and won't fund.
- ISAR
- — Indian Society for Assisted Reproduction; Indian expert consensus.
- Cochrane
- — Independent global reviewers of the underlying studies.
HFEA
UK regulator
Grey — insufficient evidence — chance of a babySourceESHRE
European society
Not for routine useNot recommended for routine clinical use.
SourceNICE
UK NHS guidance
Not addressedNot addressed in NG257.
ISAR
Indian society
Needs robust RCTsNeed robust RCTs to suggest use; very low-quality evidence in support.
SourceCochrane
Evidence base
No Cochrane review identified specifically for this add-on.
Typical cost in India
Charged as an advanced-lab add-on, ~₹15,000–40,000 (varies; often bundled).
Sources
Take this further
Sources last reviewed .